You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《高盛認股證牛熊證》 國藥回吐超過1成 本周世衛將公布疫苗評估 留意新上市長期購24483
阿思達克 05-06 11:02
正股表現:國藥(1099)日前受世衛報告消息利好急升至1年高位,今早則大幅回吐。早上低開約1.6%後跌幅擴大,最低見22.95元,為半個月低位。現報22.95元,跌約10.9%。世衛代表日前表示,將於本週末前發布對國藥(1099)及科興新冠病毒疫苗的緊急使用列表評估。此外,中國駐阿根廷大使館日前發布消息,指中國駐阿根廷大使鄒肖力與阿根廷衛生部長維佐蒂、阿根廷總統顧問尼科裡妮等代表,與國藥及阿根廷製藥企業負責人舉行會議。並且國藥與阿根廷相關企業達成共識,於阿根廷國內合作生產國藥新冠疫苗。

資金流向:觀察個股輪證資金流向,可見近期資金轉傾向部署認購證,過去3個交易日共錄得約130萬元資金流入。

產品選擇:投資者如看好,可留意屬長期的新上市國藥購24483。

國藥購24483,行使價30元,2021年11月24日到期,實際槓桿4.7倍,新上市、長期

註: 以上數據資料來自高盛認股證牛熊證網站https://www.gswarrants.com.hk/~

重要聲明:

以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account